Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


CardioMEMS’ Heart Failure Monitor Foiled At Panel By FDA Inspection Findings Of Study Bias

This article was originally published in The Gray Sheet

Executive Summary

The firm’s PMA hopes are in question after recommendations made by company nurses to investigators in the CHAMPION trial, uncovered during FDA clinical-site inspections, dominated last week’s advisory panel meeting. The panel voted 6-4 that the benefits of the device do not outweigh its risks.


Related Content

CardioMEMS Has Better Luck With FDA Advisory Panel Second Time Around
NICE Briefs: Oncotype Dx; Implantable Heart Failure Monitors; Endobronchial Valves; RF Ablation
News Briefs: FDA Program Alignment Group; CardioMEMS Panel; HCV Coverage Analysis
Washington Roundup, October 2012
FDA Takes Enforcement Action Against CardioMEMS For Alleged Clinical Trial Violations
Heart Failure Devices: Raising Roadblocks To Readmission
Cook Medical Makes Its Case For Medicare New-Tech Add-On Payments
Heart Failure Devices: Raising Roadblocks To Readmission
St. Jude: CardioMEMS’ Heart Failure Data Reflects Major Opportunity
Panel Votes Against Medtronic’s Chronicle, Offers Ideas For New Trial


Related Companies




Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts